Tekla Capital Management LLC Syndax Pharmaceuticals Inc Transaction History

Tekla Capital Management LLC

  • $2.53 Billion
  • Q2 2023

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 10, 2023
BUY
$20.64 - $26.24 $2.43 Million - $3.09 Million
117,717 New
117,717 $3 Million
Q1 2022

May 13, 2022
BUY
$14.84 - $22.15 $838,163 - $1.25 Million
56,480 New
56,480 $982,000
Q2 2019

Aug 14, 2019
SELL
$4.9 - $9.31 $702,846 - $1.34 Million
-143,438 Closed
0 $0
Q1 2019

May 14, 2019
SELL
$4.26 - $6.86 $240,954 - $388,015
-56,562 Reduced 28.28%
143,438 $753,000
Q2 2017

Aug 14, 2017
BUY
N/A
200,000
200,000 $2.79 Million

Others Institutions Holding SNDX

# of Institutions
229
Shares Held
89.5M
Call Options Held
1.01M
Put Options Held
692K
View Full List

About Syndax Pharmaceuticals Inc

SNDX Quotes by TradingView
  • Ticker SNDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,565,200
  • Market Cap $878M
  • Description
  • Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...
More about SNDX
Track This Portfolio

Track Tekla Capital Management LLC Portfolio

Follow Tekla Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tekla Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tekla Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email